SCHEMBL9659161

SCHEMBL9659161

Nc1ncnc(N)c1/N=N/c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.55
TDP1 Q9NUW8 8/20 0.55
CCNT1 O60563 1/20 0.55
CCNE2 O96020 1/20 0.55
GAA P10253 1/20 0.55
CCNE1 P24864 1/20 0.55
CDK2 P24941 1/20 0.55
CDK9 P50750 1/20 0.55
GFER P55789 1/20 0.55
KMT2A Q03164 7/20 0.50
MEN1 O00255 6/20 0.50
NPC1 O15118 6/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
LMNA P02545 3/20 0.50
ALDH1A1 P00352 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9659168 1.00 MAPT (0.55) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10918836 0.83 MAPT (0.44) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10918835 0.83 MAPT (0.44) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10708407 0.79 MAPT (0.64) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10708396 0.79 MAPT (0.64) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL5310168 0.79 MAPT (0.50) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10408855 0.74 ALDH1A1 (0.80) MAPTTDP1CCNT1CCNE2GAA
Azobenzene SCHEMBL28756037 0.71 ALDH1A1 (0.86) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10918165 0.71 ALDH1A1 (0.44) MAPTTDP1CCNT1CCNE2GAA
SCHEMBL10918162 0.71 ALDH1A1 (0.44) MAPTTDP1CCNT1CCNE2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4092314-A FROM ARYLAZOMALONONITRILE AND FORMAMIDE AND AMMONIA, AMMONIUM SALT MERCK & CO., INC. (US) 1978-05-30 US claimed
CN-118217290-B Use of soluble guanylate cyclase stimulators for the prevention and treatment of altitude pulmonary oedema 中国人民解放军军事科学院军事医学研究院 2024-10-29 CN disclosed
CN-117924280-B Substituted thienyl-5-fluoro-1H-pyrazolopyridine compound and application thereof 中国人民解放军军事科学院军事医学研究院 2024-07-12 CN disclosed
CN-118217290-A Use of soluble guanylate cyclase stimulators for the prevention and treatment of altitude pulmonary oedema 中国人民解放军军事科学院军事医学研究院 2024-06-21 CN disclosed
CN-117924280-A Substituted thienyl-5-fluoro-1H-pyrazolopyridine compound and application thereof 中国人民解放军军事科学院军事医学研究院 2024-04-26 CN disclosed
US-5089618-A Converting to N,N'-Bis(trimethylsilyl)derivative; distillation; solvolytic cleavage; hydrolysis; efficiency; high purity LONZA LTD. (CH) 1992-02-18 US disclosed
US-4997939-A Reduction, cyclization KOHJIN CO., LTD. (JP) 1991-03-05 US disclosed
US-4861883-A REACTING ARYLAZONONITRILE WITH FORMIC ACID IN PRESENCE OF AMMONIA, CYCLIZATION, REMOVAL AMMONIA, THEN CATALYTIC REDUCTION KOHJIN CO., LTD. (JP) 1989-08-29 US disclosed
EP-0118597-B1 PROCESS FOR PREPARING ADENINE Kohjin Co., Ltd. (JP) 1987-04-08 EP disclosed
US-4503228-A 2-(Pyridinyl)-4,5,6-pyrimidinetriamines STERLING DRUG INC. (US) 1985-03-05 US disclosed
EP-0045503-B1 PROCESS FOR PREPARING ADENINE Kohjin Co., Ltd. (JP) 1984-11-14 EP disclosed
US-4473571-A 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use STERLING DRUG INC. (US) 1984-09-25 US disclosed
EP-0118597-A2 Process for preparing adenine Kohjin Co., Ltd. (JP) 1984-09-19 EP disclosed
EP-0045503-A1 Process for preparing adenine Kohjin Co., Ltd. (JP) 1982-02-10 EP disclosed
US-4092314-A FROM ARYLAZOMALONONITRILE AND FORMAMIDE AND AMMONIA, AMMONIUM SALT MERCK & CO., INC. (US) 1978-05-30 US disclosed